Form 4: Moderna President Stephen Hoge Reports Stock Transactions

Moderna President Stephen Hoge reported the conversion of restricted stock units into common stock and the subsequent sale of shares to cover tax obligations.

Summary

• Stephen Hoge, President of Moderna, Inc., reported transactions involving the company's common stock.
• On December 1, 2025, 652 restricted stock units (RSUs) converted into 652 shares of common stock on a one-for-one basis.
• Concurrently, 316 shares of common stock were disposed of at a price of $25.98 per share to satisfy tax withholding obligations related to the RSU vesting.
• Following these transactions, Hoge directly beneficially owns 1,454,905 shares of common stock.
• Indirect beneficial ownership includes 4,116 shares through Valhalla, LLC, and 151,933 shares through a trust for the benefit of his spouse and children.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction involving the vesting of restricted stock units and subsequent tax-related share disposition, which is a neutral event in terms of company performance or outlook.

Positives

• Vesting of 652 restricted stock units, indicating the fulfillment of compensation terms.
• Increase in direct common stock ownership by 652 shares prior to tax withholding.

Negatives

• A total of 316 shares of common stock were sold to cover tax liabilities, reducing direct ownership.

Future Outlook

N/A. This filing reports past transactions and does not provide forward-looking statements or guidance.

Industry Context

N/A. This is a routine insider transaction report and does not provide information relevant to broader industry trends or competitive analysis.

Related Party Transactions

• Indirect beneficial ownership of 151,933 shares is held by a trust for the benefit of Dr. Hoge's spouse and children, of which his spouse is a trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any.

Stakeholder Impact

• Shareholders: Minimal impact, as this is a routine, pre-planned executive compensation transaction.
• Employees: No direct impact on the broader employee base.
• Management: Stephen Hoge's compensation structure is partially realized through this vesting event.

Key Dates

Keywords

Moderna, MRNA, Stephen Hoge, Insider Transaction, Form 4, Restricted Stock Units, Executive Compensation, Stock Vesting, Tax Withholding